Indaptus Therapeutics (INDP) Total Non-Current Liabilities (2020 - 2024)
Indaptus Therapeutics' Total Non-Current Liabilities came in at $4,007 for Q3 2024, down 95.8% from $95,237 a year earlier and down 85.5% from the prior quarter.
Powered by 
Analysis
Indaptus Therapeutics (INDP) Total Non-Current Liabilities (2020 - 2024) Analysis & Trends
At the end of FY2023, Indaptus Therapeutics' Total Non-Current Liabilities was $73,348.
- Total Non-Current Liabilities carries a three-year compound annual growth rate of -58.5% (FY2020 to FY2023).
- Going back by year, Total Non-Current Liabilities was $72,862 in FY2021 (-92.9%) and $1.03 million in FY2020.
- The Q3 2024 figure represents the lowest quarterly Total Non-Current Liabilities in data going back to Q4 2020.
- Year-over-year, Total Non-Current Liabilities has declined for three consecutive quarters, with growth averaging 50.4% over the last five quarters.
- The fastest year-over-year change in Total Non-Current Liabilities over five years came in Q2 2023 (growth of 316.3%), and the weakest in Q2 2022 (a decline of 96.1%).
- Business Quant data shows INDP's Total Non-Current Liabilities at $27,579 (Q2 2024), $50,664 (Q1 2024) and $73,348 (Q4 2023) in the three quarters before Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 5.92 Bn |
| 10 | Indaptus Therapeutics | 210.93 Mn | 183.54 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 4,007.00 |
| Jun 30, 2024 | 27,579.00 |
| Mar 31, 2024 | 50,664.00 |
| Dec 31, 2023 | 73,348.00 |
| Sep 30, 2023 | 95,237.00 |
| Jun 30, 2023 | 116,170.00 |
| Mar 31, 2023 | 136,669.00 |
| Sep 30, 2022 | 4,949.00 |
| Jun 30, 2022 | 27,907.00 |
| Mar 31, 2022 | 50,516.00 |
| Dec 31, 2021 | 72,862.00 |
| Jun 30, 2021 | 716,000.00 |
| Mar 31, 2021 | 883,000.00 |
| Dec 31, 2020 | 1.03 Mn |
API Access
Indaptus Therapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=INDP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "INDP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=INDP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();